[Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?]

MeSH terms

• Anti-Bacterial Agents / therapeutic use
• Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
• Anti-Ulcer Agents / therapeutic use
• Clinical Trials as Topic
• Confidence Intervals
• Duodenal Ulcer / chemically induced
• Duodenal Ulcer / drug therapy
• Duodenal Ulcer / etiology
• Enzyme Inhibitors / therapeutic use
• Gastritis / chemically induced*
• Gastritis / etiology*
• Helicobacter Infections / complications*
• Helicobacter Infections / drug therapy
• Helicobacter pylori*
• Histamine H2 Antagonists / therapeutic use
• Humans
• Multicenter Studies as Topic
• Naproxen / therapeutic use
• Omeprazole / therapeutic use
• Peptic Ulcer / chemically induced*
• Peptic Ulcer / drug therapy
• Peptic Ulcer / etiology*
• Prospective Studies
• Ranitidine / therapeutic use
• Risk Factors
• Stomach Ulcer / chemically induced
• Stomach Ulcer / drug therapy
• Stomach Ulcer / etiology